DECN Stock UPDATES Decision Diagnostics Corp (DECN) 0.4000 08/30/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Decision Diagnostics Corp (DECN) 0.4000 $DECN

David Defeats Goliath (Again), DECN and Pharma Tech Solutions Awarded Victory Over Johnson & Johnson Lifescan in USPTO Final Ruling
Marketwire - Mon Aug 11, 8:20AM CDT
Decision Diagnostics Corp. (PINKSHEETS: DECN), the manufacturer of an exclusive worldwide sales, service and regulatory processes agent for its popular GenStrip(TM) glucose test strip, specifically designed to work with Johnson & Johnson's LifeScan Ultra family of glucose testing meters, announced today that on August 6, 2014, the United States Patent and Trademark Office, Patent Trial and Appeal Board has sustained, in a final ruling, the company's challenge to Johnson & Johnson Lifescan's Patent 7,250,105, specifically "claims 1-3 ... for obviousness, ... by a preponderance of the evidence." These three claims are used by J&J Lifescan as the foundation of their patent infringement lawsuit against DECN and Pharma Tech. The USPTO Judge Panel has ruled these claims as "unpatentable."

Decision Diagnostics Announces Posting and Airing of Its New GenStrip Commercial Titled "Monolith"
Marketwire - Mon Mar 31, 8:15AM CDT
Decision Diagnostics Corp. (OTCBB: DECN), the exclusive worldwide sales, service and regulatory processes agent for the Shasta GenStrip(TM), the Green Glucose Test Strip, specifically designed to work with the Johnson & Johnson's (NYSE: JNJ) LifeScan Ultra family of glucose testing meters, today announced that its Pharma Tech Solutions subsidiary has completed and will air in many regions in the U.S. its new commercial video titled "GenStrip: Monolith." The video is available for viewing at:

Decision Diagnostics Announces Engagement of Mark Krakauer to Head Up Genstrip Private Label Sales Efforts
Marketwire - Tue Mar 11, 8:15AM CDT
Decision Diagnostics Corp. (OTCQB: DECN), the exclusive worldwide sales, service and regulatory processes agent for the popular Shasta GenStrip(TM), the unique Green Glucose Test Strip, specifically designed to work with the Johnson & Johnson's LifeScan Ultra family of glucose testing meters, today announced that that the Company has engaged Mark Krakauer to lead the company's private label marketing strategy. Mr. Krakauer is President of MWK Marketing, Inc. and a founder of the Private Label Manufacturers Association.

Decision Diagnostics Announces Agreement for Funding of Its Prosecution of Anti-Trust and False Advertising Suits Against Division of Johnson & Johnson
Marketwire - Tue Feb 18, 10:25AM CST
Decision Diagnostics Corp. (OTCQB: DECN), the exclusive worldwide sales, service and regulatory processes agent for the popular Shasta GenStrip(TM), the unique Green Glucose Test Strip, specifically designed to work with the Johnson & Johnson's LifeScan Ultra family of glucose testing meters, today announced that that the Company has executed a Terms Agreement with a major east coast based litigation prosecution fund for the financing of the prosecution of DECN's countersuits brought against LifeScan, Inc., a division of Johnson and Johnson, Inc. DECN has asserted claims for anti-trust violations and false advertising.

Decision Diagnostics Announces Agreement for the Funding of Its Prosecution of Anti-Trust and False Advertising Suits Against Division of Johnson & Johnson
Marketwire - Fri Feb 14, 2:30PM CST
Decision Diagnostics Corp. (OTCQB: DECN), the exclusive worldwide sales, service and regulatory processes agent for the popular Shasta GenStrip(TM), the unique Green Glucose Test Strip, specifically designed to work with the Johnson & Johnson's LifeScan Ultra family of glucose testing meters, today announced that that the Company has executed a Terms Agreement with a major east coast based litigation prosecution fund for the financing of the prosecution of DECN's countersuits brought against LifeScan, Inc., a division of Johnson and Johnson, Inc. DECN has asserted claims for anti-trust violations and false advertising.

Decision Diagnostics Announces Posting and Airing of Its New GenStrip Commercial Titled "A Winter Patchwork"
Marketwire - Wed Jan 15, 8:15AM CST
Decision Diagnostics Corp. (OTCBB: DECN), the exclusive worldwide sales, service and regulatory processes agent for the Shasta GenStrip(TM), the Green Glucose Test Strip, specifically designed to work with the Johnson & Johnson's (NYSE: JNJ) LifeScan Ultra family of glucose testing meters, today announced that its Pharma Tech Solutions subsidiary has completed and is airing in many regions in the U.S. its new commercial video titled "GenStrip: A Winter Patchwork." The video is available for viewing at: http://shastagenstrip.com/winter_ad.html or http://youtu.be/j0njOGSSKtQ.

Decision Diagnostics Corp concludes USD12.5m (non-dilutive) credit facility with Platinum Credit Management
M2 - Fri Dec 20, 5:46AM CST
Decision Diagnostics Corp (OTCBB ECN) reported on Thursday the completion of its USD12.5m revolving credit line with Alpha Credit Resources LLC, a division of Platinum Credit Management LP of New York, NY.

Decision Diagnostics Closes $12.5 Million (Non-Dilutive) Credit Facility With Division of Platinum Credit Management
Marketwire - Thu Dec 19, 8:15AM CST
Decision Diagnostics Corp. (OTCBB: DECN) the exclusive worldwide sales, service and regulatory processes agent for the popular Shasta GenStrip(TM), the unique Green Glucose Test Strip, specifically designed to work with the Johnson & Johnson's (NYSE: JNJ) LifeScan Ultra family of glucose testing meters, today announced that that the Company has closed its agreement for a $12.5 million revolving credit line from Alpha Credit Resources, LLC, a division of Platinum Credit Management LP of New York, NY.

Decision Diagnostics Receives Mandate From U.S. Court of Appeals for the Federal Circuit in the Long Running Dispute With J&J Division
Marketwire - Tue Dec 17, 8:15AM CST
Decision Diagnostics Corp. (OTCBB: DECN), the exclusive worldwide sales, service and regulatory processes agent for the popular Shasta GenStrip(TM), the unique Green Glucose Test Strip, specifically designed to work with the Johnson & Johnson's (NYSE: JNJ) LifeScan Ultra family of glucose testing meters, today announced that on December 11, 2013 the United States Court of Appeals for the Federal Circuit issued its Mandate, making its November 4, 2013 ruling final. Plaintiffs Lifescan Scotland, Ltd, and Lifescan, Inc., divisions of Johnson & Johnson failed to appeal the initial Circuit Court ruling during the statutory period of time allowed, although they still have time to appeal to the U.S. Supreme Court.

OTC Daily Alert Stock Watch - Decision Diagnostics Corp. (OTCQB: DECN)
WorldStockWire - Tue Sep 17, 6:30PM CDT
OTC Daily Alert tracks stocks daily and is pleased to offer features on public companies. Investors can receive FREE Stock Alerts and company news and profiles by visiting OTC Daily Alert at the following: http://www.otcdailyalert.com

Decision Diagnostics Corp. Announces Completion and Airing of Its New Genstrip Video Titled "A Patchwork of Life"
Marketwire - Tue Sep 10, 8:20AM CDT
Decision Diagnostics Corp. (OTCBB: DECN), the exclusive worldwide sales, service and regulatory processes agent for the Shasta GenStrip(TM), the Green Glucose Test Strip, specifically designed to work with the Johnson & Johnson's (NYSE: JNJ) LifeScan Ultra family of glucose testing meters, today announced that its Pharma Tech Solutions subsidiary has completed and is airing its new commercial video titled "Genstrip: A Patchwork of Life." The video is available for viewing at: http://shastagenstrip.com/shasta_ad.html or http://youtu.be/zzBuHxb-rlM. The company will publish the media schedule for future airings in the coming days.

Decision Diagnostic's GenStrip Could Change the Blood Glucose Market
Marketwire - Tue Sep 03, 6:56AM CDT
The glucose monitoring industry is growing at 25% annually and could grow to over $30 billion by 2017. Four players dominate the market, with Johnson & Johnson being the market share leader with over 30% market share. J&J's glucose monitoring system is the LifeScan Ultra with consists of LifeScan Ultra meters and test strips and have annual sales over $4 billion but an upstart player, Decision Diagnostics Corp. (OTCBB: DECN), is entering the market with a new low-cost (about 50% lower), high-performance test strip, which could gain significant market share at the expense of the leaders, according to a new report by Equity Brief.

Decision Diagnostics Subsidiary Makes Move and Sues Two Johnson and Johnson Divisions for False Advertising in Ongoing Battle
Marketwire - Thu Aug 01, 8:15AM CDT
Decision Diagnostics Corp. (OTCBB: DECN), the exclusive worldwide sales, service and regulatory processes agent for the Shasta GenStrip(TM), the Green Glucose Test Strip, specifically designed to work with Johnson & Johnson's (NYSE: JNJ) LifeScan Ultra family of glucose testing meters, announced today the filing of counterclaims by its subsidiary Pharma Tech Solutions, Inc. for false and misleading advertising against two of Johnson & Johnson, Inc. ("J&J" wholly owned subsidiaries, Lifescan, Inc., and Lifescan Scotland, LTD (collectively "Lifescan" . The company and its Pharma Tech Solutions, Inc. ("Pharma Tech" subsidiary have been in patent litigation with the Lifescan subsidiaries since September 2011.

DECN Steps Into Role of White Knight by Offering Strategic Version of GenStrip(TM) Exclusively for Medicare Competitive Bidding Program
Marketwire - Wed May 29, 8:15AM CDT
Decision Diagnostics Corp. (OTCBB: DECN), the exclusive worldwide sales, service and regulatory processes agent for the Shasta GenStrip(TM), the Green Test Strip, specifically designed to work with the Johnson & Johnson's (NYSE: JNJ) LifeScan family of glucose testing meters, announced today that the company and its subsidiary PharmaTech Solutions, Inc. have launched a strategically packaged version of the Shasta GenStrip(TM) for sale to companies who service the "direct to patient" fulfillment (mail order and durable medical goods) channels. This channel, estimated to command a share in excess of 25% of all diabetes testing, takes on increased importance as a result of Medicare's mandated competitive bidding, which is anticipated to lower reimbursement of supplies and medical goods for diabetics by approximately 67% beginning July 1, 2013 and thus to lower market diversity in this important and traditional channel.

Decision Diagnostics Corp. and Its Subsidary PharmaTech Solutions Seek to End Pharma Giant's Alleged Restraint of Trade Tactics
Marketwire - Fri Apr 05, 8:20AM CDT
Decision Diagnostics Corp. (OTCBB: DECN), the exclusive world-wide sales, service and regulatory processes agent for the Shasta GenStrip, the revolutionary at-home glucose test strip specifically designed to work with the Johnson & Johnson's LifeScan family of glucose testing meters, announced today that on March 28, 2013 the company and its subsidiary PharmaTech Solutions, Inc. filed antitrust counterclaims against LifeScan, Inc. and LifeScan Scotland Ltd. (collectively, "LifeScan" in a patent action brought by LifeScan (2011cv04494) that is presently pending in the Northern District of California. DECN and PharmaTech are defendants in that action. DECN is a leading provider of prescription and non-prescription diagnostics, home testing products for the chronically ill and a premier developer of revolutionary cell phone centric e-health products and technologies.

Decision Diagnostics Corp. and Its Subsidiary PharmaTech Solutions, Inc. Sue Johnson & Johnson Division LifeScan, Inc. and LifeScan Scotland Ltd. for Antitrust Violations
Marketwire - Thu Apr 04, 11:32AM CDT
Decision Diagnostics Corp. (OTCBB: DECN) the exclusive world-wide sales, service and regulatory processes agent for the Shasta GenStrip, the revolutionary at-home glucose test strip specifically designed to work with the Johnson & Johnson's LifeScan family of glucose testing meters, announced today that on March 28, 2013 the company and its subsidiary PharmaTech Solutions, Inc. filed antitrust counterclaims against LifeScan, Inc. and LifeScan Scotland, Ltd. (collectively, "LifeScan" in a patent action brought by LifeScan (2011cv04494) that is presently pending in the Northern District of California. DECN and PharmaTech are defendants in that action. DECN is a leading provider of prescription and non-prescription diagnostics, home testing products for the chronically ill and a premier developer of revolutionary cell phone centric e-health products and technologies.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Pollo AI Unveils York AI: Automating Social Growth

Updated Category News Views 278

York AI Debuts as the New Kid on the Block Amid the hustle and bustle of a tech-savvy Singapore, Pollo AI’s latest offering, York AI, sashays onto the scene with the promise of putting social media growth on cruise control. We're talking about a digital sidekick that seems to know your online persona better than you do. It’s tailored for everyone from the small-time...

Continue Reading
Engrain's Geospatial Innovation Pushes Property Mapping Forward

Updated Category News Views 94

Pushing the Boundaries of Property Mapping How far can you expand the boundaries of property mapping tech? Well, Engrain seems hell-bent on finding out by cranking their innovations up a notch. The Denver-based stalwart in interactive mapping is rolling out some mind-boggling enhancements that could redefine how the multifamily housing sector operates. This isn't just...

Continue Reading
Pine Tree Bets Big on Tulsa Hills Shopping Center

Updated Category News Views 132

Pine Tree's Latest Move in Retail Real Estate Ya ever watch a company make a move so aligned with its playbook that it feels like a script straight outta the boardroom? That's Pine Tree with its recent snag of Tulsa Hills Shopping Center for a cool $108 million. This ain't just any retail spot; it's a bustling hub nestled within the posh outskirts of Jenks, Oklahoma....

Continue Reading
TOYO Slips on Earnings Amid Strategic Expansion

Updated Category News Views 206

TOYO's Solar Journey: Ups and Downs If there's one thing riding high on volatility these days, it's solar energy. TOYO Co., Ltd. (Nasdaq: TOYO) spilled the beans on Q3 2026, and oh boy, it's a mixed bag. Revenue Jumps, Yet Profitability Takes a Hit Let's cut to the chase: the third quarter served up a 4.8% dip in revenue year-over-year, landing at $129 million, though it...

Continue Reading
Intel Hit by Securities Law Suit Amid PC Market Struggles

Updated Category News Views 69

Intel Faces the Music: Legal Battles Unfold So it seems Intel's got itself in a kettle of fish. The tech giant is being dragged into a courtroom dance, courtesy of a class action lawsuit led by DJS Law Group. Shareholders who snapped up Intel shares between July 23 and October 29, 2026, might be scratching their heads, wondering if they bought into a bit of a mirage. A...

Continue Reading
AvidXchange Acquisition Faces Fairness Investigation

Updated Category News Views 31

Unpacking the AvidXchange Turmoil Staring at the ticker tape feels like watching a drama unfold, and today it's all about AvidXchange Holdings, Inc. (NASDAQ: AVDX). Levi & Korsinsky, LLP has launched an investigation into the fairness of its acquisition, and let me tell you, when the suits start poking around, it means someone smells a rat. The deal in question? A buyout...

Continue Reading
Panduit's AI Cooling Lab Boosts Data Center Innovation

Updated Category News Views 21

Innovation in Cooling: Panduit's Latest Move You hear "AI" and "data center" together and you know it's not gonna be business as usual. Here's Panduit throwing another log on the fire with their newly minted AI Cooling Lab. Panduit's a big cheese in the electrical and network infrastructure world. They've taken their Thermal Lab, given it a face-lift, and now, they’re...

Continue Reading
Sasol AGM Resolutions Passed in One Swift Swing

Updated Category News Views 213

Sasol's AGM Delivers Smooth Sailing for Shareholders Can't say I'm surprised, but Sasol's annual general meeting on the 13th of November went off without a hitch—unless, of course, you're one of those folks who just loves fireworks at these gatherings. The entire set of resolutions danced through with a resounding "Aye," making it one heck of a day for anyone banking on...

Continue Reading
Quantum X and Everest Cloud Partner in South Asia Push

Updated Category News Views 42

An Unlikely Alliance for Cutting-Edge Tech You gotta admit, the fusion of a U.S.-based tech outfit with a Nepalese cloud provider wasn't the market move anyone saw coming. But here we are—Quantum X is hitching its quantum computing dreams to Everest Cloud's solid local foothold across six South Asian markets. We're talking Nepal, India, Bangladesh, Bhutan, Sri Lanka,...

Continue Reading
DHL Leverages Robust Growth in Resilient Supply Chains

Updated Category News Views 31

Supply Chain Resilience: A Strategic Game Changer Market volatility's got its teeth in the game, and everyone in logistics knows it. DHL Supply Chain isn't just sitting back; they're riding the wave of change, snagging a 12% revenue bump in 2026. It's not your typical headline growth, either. More like the kind of growth that gets logistics gurus eyeing those contract...

Continue Reading

Top 5 Most Recently Viewed Articles

Analysts Adjust Forecasts for Ford Motor Company Ahead of Q3 Earnings

Updated Category News Views 244

Ford Motor Company Set to Announce Q3 Earnings Results Ford Motor Company (NYSE:F) is preparing to release its earnings results for the third quarter shortly. Investors and market analysts are keeping a close eye on what the iconic American automotive manufacturer will report. Analysts' Earnings Expectations Current expectations from analysts suggest that Ford is likely...

Continue Reading
Erithmitic Inc. Unveils Navigate Re: A New Era in Investment

Updated Category News Views 168

Erithmitic Inc. Introduces Navigate Re Limited Erithmitic Inc., a forward-thinking alternative asset manager, has recently made waves in the financial sector by introducing its new reinsurance entity, Navigate Re Limited. This strategic initiative reflects the company’s commitment to enhance its investment capabilities while laying the groundwork for significant future...

Continue Reading
Torres Trade Law Earns Prestigious Recognition in Rankings

Updated Category News Views 141

Celebrating Outstanding Achievements in Trade Law Torres Trade Law, PLLC, renowned for its commitment to international trade law, has made headlines following its recent recognition from the esteemed Chambers and Partners. The firm is thrilled to announce that its Founder and Managing Member, Olga Torres, has been nationally ranked for her outstanding work in the field of...

Continue Reading
Prudent Growth Partners Achieves Success with Town Center Sale

Updated Category News Views 163

Prudent Growth Partners Completes Successful Sale Prudent Growth Partners, LLC, a leading private equity real estate firm, recently announced the completion of the sale of Rolesville Town Center, marking an exceptional achievement for the company. The property was sold for $4.5 million, reflecting a strategic financial decision that continues to highlight the firm’s...

Continue Reading
Emerging Trends and Market Insights in Industrial Recycling Services

Updated Category News Views 162

Growth of Industrial Packaging Recycling Services The industrial packaging recycling services market is on a dynamic growth trajectory, boosting its size from USD 67.76 billion and aiming to reach USD 100.65 billion within a decade. This rapid expansion highlights a significant global trend towards eco-friendly solutions in packaging and waste management, emphasizing...

Continue Reading